Rockwell Medical
(NASDAQ) RMTI
Rockwell Medical Financials at a Glance
Market Cap
$26.81M
Revenue (TTM)
$67.68M
Net Income (TTM)
-$5.40M
EPS (TTM)
-$0.15
P/E Ratio
-4.62
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$0.67
Volume
311
Open
$0.67
Price
$0.67
Volume
311
Open
$0.67
Previous Close
$0.68
Daily Range
$0.67 - $0.68
52-Week Range
$0.60 - $2.10
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$0.67
Volume
311
Open
$0.67
Previous Close
$0.68
Daily Range
$0.67 - $0.68
52-Week Range
$0.60 - $2.10
Estimated Earnings Date
Aug 13, 2026
RMTI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rockwell Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
157
CEO
Mark Strobeck, PhD
Website
www.rockwellmed.comHeadquarters
Wixom, MI 48393, US
RMTI Financials
Key Financial Metrics (TTM)
Gross Margin
17.07%
Operating Margin
-7.11%
Net Income Margin
-7.98%
Return on Equity
-15.41%
Return on Capital
-9.49%
Return on Assets
-9.41%
Earnings Yield
-21.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$26.81M
Shares Outstanding
39.47M
Volume
311
Avg. Volume
279.42K
Financials (TTM)
Gross Profit
$11.55M
Operating Income
-$4.81M
EBITDA
-$2.59M
Operating Cash Flow
$2.66M
Capital Expenditure
-$904.00K
Free Cash Flow
$1.76M
Cash & ST Invst.
$23.89M
Total Debt
$14.39M
Rockwell Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.34M
-8.3%
Gross Profit
$2.90M
-4.8%
Gross Margin
16.71%
N/A
Market Cap
$26.81M
N/A
Market Cap/Employee
$109.89K
N/A
Employees
244
N/A
Net Income
-$1.61M
-5.9%
EBITDA
-$812.00K
-16.2%
Quarterly Fundamentals
Total Cash
$23.89M
+37.8%
Total Debt
$14.39M
+11.8%
Accounts Receivable
$8.83M
-8.7%
Inventory
$3.06M
-39.4%
Long Term Debt
$11.70M
+9.0%
Short Term Debt
$2.69M
+26.1%
Return on Assets
-9.41%
N/A
Return on Invested Capital
-10.12%
N/A
Free Cash Flow
-$592.00K
+83.3%
Operating Cash Flow
-$167.00K
+95.2%